EX-4.01 2 ex4-01.htm EX-4.01 Exhibit 4.01 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES. COMMON STOCK PURCHASE WARRANT ADAPTI, Inc. Warrant Initial Shares: 240,000 Exercise Date: November 18, 2025 THIS COMMON STOCK PURCHASE WARRANT (the “ Warrant ”) certifies that, for value …
Open exhibit ↗Current Report · Items 1.01, 3.02, 5.02, 9.01 · 8-K
Adapti, Inc.
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 1.01 Entry into a Material Definitive Agreement The disclosure in Item 5.02 of this Current Report on Form 8-K is incorporated herein by reference into this Item.
Company context
Current securities
Recent company filings
- Non-Reliance on Previously Issued Financial Statements or a Related Audit ReportJul 20, 2026
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Other EventsApr 6, 2026
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsMar 6, 2026
- 10-Q filingFeb 17, 2026
- 10-Q filingNov 19, 2025
Disclosure sections
Item 1.01Item 1.01 - Entry into Material Agreement
Item
1.01 Entry into a Material Definitive Agreement
The
disclosure in Item 5.02 of this Current Report on Form 8-K is incorporated herein by reference into this Item.
Item 3.02Item 3.02 - Unregistered Sales of Equity
Item
3.02 Unregistered Sale of Equity Securities
The
disclosure in Item 5.02 of this Current Report on Form 8-K regarding the issuance of the Warrant (as defined below) to Mr. Karim is incorporated
by reference into this Item. The Warrant is exempt from the registration requirements of the Securities Act of 1933 by virtue of Section
4(a)(2) thereof and/or Regulation D promulgated thereunder.
Item
5.02 Departure of Director or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers
Appointment
of Omar Karim as Chief Revenue Officer.
On
November 18, 2025 (“Effective Date”), Adapti, Inc. (the “Company”) appointed Omar Karim to serve as the Chief
Revenue Officer of the Company.
Omar
Karim, age 44, was appointed to serve as our chief revenue officer in November 2025. From 2002 until November 2025, Mr. Karim
was a founder and served as president of MAB Ventures Digital Marketing Agency, LLC until its sale. MAB is a full-service performance
marketing agency that specializes in brand strategy, creative execution, end-to-end digital technology, and engagement. Earlier in his
career, Mr. Karim managed an automobile dealership, worked as vice-president of business development for PayDivvy, a financial technology
startup, which was acquired by HigherOne in 2013, and was a founding member of Fitlab, LLC, an integrated health and wellness venture.
Mr. Karim graduated from the University of Southern California and holds a BA in international relations with a double minor in Business
Administration and Business Technology.
Omar
Karim Employment Agreement and Related Contracts
On
the Effective Date, in connection with Mr. Karim’s employment, we entered into an at-will employment agreement (the “Employment
Agreement”) with Mr. Karim. Pursuant to the terms of the Employment Agreement, Mr. Karim will receive a base salary of $180,000
per annum. Such base salary will accrue, but not be payable until the earlier of (i) the Company’s board of directors (“Board”)
determining that the Company is sufficiently capitalized or (ii) the Company raises an aggregate of $1,000,000 in net proceeds from the
sale of its equity securities in one or more transactions (collectively, the “Funding Threshold”). Upon the Funding Threshold,
the Company will be required to pay all accrued but unpaid base salary and such base salary will automatically increase to $300,000 per
annum.
Upon
completion of the Funding Threshold, if Mr. Karim’s employment is terminated for any reason other than “Cause”, “Permanent
Disability”, or death, each as described in the Employment Agreement (an “Elective Termination”), then the Company
will be required to pay Mr. Karim six (6) months of continued base salary in effect at the time of termination.
Common
Stock Purchase Warrant
In
addition, on the Effective Date, the Company issued to Mr. Karim, a warrant to purchase up to 240,000 shares of common stock of the Company
(the “Warrant”). The Warrant has a term of five (5) years, and an exercise price per share of $3.08, subject to adjustment
for stock splits and dividends. The Warrant vests as follows: (i) 48,000 shares vest on the Effective Date, and (ii) an additional 48,000
shares vest on each yearly anniversary thereafter such that the Warrant is fully vested on the four (4) year anniversary of the Effective
Date. The Warrant also vests (i) fully upon a “change of control” of the Company, as defined in the Warrant or (ii) ratably
from the most recently completed vesting period until the date of any Elective Termination.
Confidential
Information and Invention Assignment Agreement
In
addition, Mr. Karim entered into the Company’s standard confidential information and invention assignment agreement (“Assignment
Agreement”) governing the ownership of any inventions and confidential information.
There
were no arrangements pursuant to which Mr. Karim was appointed as Chief Revenue Officer. There are no family relationships between Mr.
Karim and any of the directors or officers of the Company or any of its subsidiaries.
The
foregoing summary of the Employment Agreement, Warrant and Assignment Agreement are qualified in their entirety by the respective terms
of the Employment Agreement, Warrant, and Assignment Agreement, which are attached to this Current Report as Exhibits 10.01, 4.01, and
10.02, respectively.
Item 5.02Item 5.02 - Departure/Election of Directors
Item
5.02 Departure of Director or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers
Appointment
of Omar Karim as Chief Revenue Officer.
On
November 18, 2025 (“Effective Date”), Adapti, Inc. (the “Company”) appointed Omar Karim to serve as the Chief
Revenue Officer of the Company.
Omar
Karim, age 44, was appointed to serve as our chief revenue officer in November 2025. From 2002 until November 2025, Mr. Karim
was a founder and served as president of MAB Ventures Digital Marketing Agency, LLC until its sale. MAB is a full-service performance
marketing agency that specializes in brand strategy, creative execution, end-to-end digital technology, and engagement. Earlier in his
career, Mr. Karim managed an automobile dealership, worked as vice-president of business development for PayDivvy, a financial technology
startup, which was acquired by HigherOne in 2013, and was a founding member of Fitlab, LLC, an integrated health and wellness venture.
Mr. Karim graduated from the University of Southern California and holds a BA in international relations with a double minor in Business
Administration and Business Technology.
Omar
Karim Employment Agreement and Related Contracts
On
the Effective Date, in connection with Mr. Karim’s employment, we entered into an at-will employment agreement (the “Employment
Agreement”) with Mr. Karim. Pursuant to the terms of the Employment Agreement, Mr. Karim will receive a base salary of $180,000
per annum. Such base salary will accrue, but not be payable until the earlier of (i) the Company’s board of directors (“Board”)
determining that the Company is sufficiently capitalized or (ii) the Company raises an aggregate of $1,000,000 in net proceeds from the
sale of its equity securities in one or more transactions (collectively, the “Funding Threshold”). Upon the Funding Threshold,
the Company will be required to pay all accrued but unpaid base salary and such base salary will automatically increase to $300,000 per
annum.
Upon
completion of the Funding Threshold, if Mr. Karim’s employment is terminated for any reason other than “Cause”, “Permanent
Disability”, or death, each as described in the Employment Agreement (an “Elective Termination”), then the Company
will be required to pay Mr. Karim six (6) months of continued base salary in effect at the time of termination.
Common
Stock Purchase Warrant
In
addition, on the Effective Date, the Company issued to Mr. Karim, a warrant to purchase up to 240,000 shares of common stock of the Company
(the “Warrant”). The Warrant has a term of five (5) years, and an exercise price per share of $3.08, subject to adjustment
for stock splits and dividends. The Warrant vests as follows: (i) 48,000 shares vest on the Effective Date, and (ii) an additional 48,000
shares vest on each yearly anniversary thereafter such that the Warrant is fully vested on the four (4) year anniversary of the Effective
Date. The Warrant also vests (i) fully upon a “change of control” of the Company, as defined in the Warrant or (ii) ratably
from the most recently completed vesting period until the date of any Elective Termination.
Confidential
Information and Invention Assignment Agreement
In
addition, Mr. Karim entered into the Company’s standard confidential information and invention assignment agreement (“Assignment
Agreement”) governing the ownership of any inventions and confidential information.
There
were no arrangements pursuant to which Mr. Karim was appointed as Chief Revenue Officer. There are no family relationships between Mr.
Karim and any of the directors or officers of the Company or any of its subsidiaries.
The
foregoing summary of the Employment Agreement, Warrant and Assignment Agreement are qualified in their entirety by the respective terms
of the Employment Agreement, Warrant, and Assignment Agreement, which are attached to this Current Report as Exhibits 10.01, 4.01, and
10.02, respectively.